Effect of biphosphonates on teleangiectasia in irradiated breast cancer patients

Effect of biphosphonates on teleangiectasia in irradiated breast cancer patients - The biphosphonate modulation of telangiectasia study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36371

Enrollment

Registered

2011-05-26

Start date

2011-02-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biphosphonates and telangiectasia in irradiated breast cancer patients.

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: radiotherapie on breast > 6 months ago will receice biphosphonate age >

Exclusion criteria

Exclusion criteria: breast radiotherapy

Design outcomes

Secondary

Measure	Time frame
To determine the effects of biphosphonates on radiation induced micro-lymphovascular damage by comparison of biopsy samples of skin prior to and after treatment with a biphosphonate.	—

Primary

Measure	Time frame
To determine the effects of biphosphonates on radiation induced microvascular damage by comparison of biopsy samples of skin prior to and 4 months after treatment with a biphosphonate.	—

Countries

Netherlands

Outcome results